[1] De Gottardi A, Sempoux C, Berzigotti A.Porto-sinusoidal vascular disorder[J].J Hepatol, 2022, 77(4):1124-1135. [2] Wöran K, Semmler G, Jachs M, et al.Clinical course of porto-sinusoidal vascular disease is distinct from idiopathic noncirrhotic portal hypertension[J].Clin Gastroenterol Hepatol, 2022, 20(2):e251-e266. [3] Rajesh S, Mukund A, Sureka B, et al.Non-cirrhotic portal hypertension: an imaging review[J].Abdom Radiol (NY), 2018, 43(8):1991-2010. [4] 刘海博,朴秉国,刘静.特发性非肝硬化门静脉高压症影像学研究进展[J]. 人民军医,2019,62(7):658-661. [5] Kang J H, Kim D H, Kim S Y, et al.Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI[J].Abdom Radiol (NY), 2021, 46(5):1891-1903. [6] 张誉,杨永峰.特发性非硬化性门静脉高压诊治进展[J].中华肝脏病杂志,2021,29(1):87-91. [7] Gioia S, Riggio O, Nardelli S, et al.Identifying patients at high risk of developing non-cirrhotic portal hypertension[J].Hepat Med, 2021, 13:105-111. [8] Zuo C, Chumbalkar V, Ells P F, et al.Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies[J].Hepatol Int, 2017, 11(5):452-460. [9] de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno Ⅶ - Renewing consensus in portal hypertension[J].J Hepatol, 2022, 76(4):959-974. |